Antibody

7개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved7 programs
AntibodyLimited DatastaleAmgenPhase 2

Panitumumab-IRDye800 (Panitumumab-IRDye800)

Pancreatic Adenocarcinoma · Malignant Brain Neoplasm

#MalignantBrainNeoplasm#Antibody#Phase2#monoclonal-antibody#PancreaticAdenocarcinoma+1
Trials 11Status Recruiting
AntibodyLimited DatastaleBristol Myers SquibbPreclinical

pembrolizumab (Keytruda, Ipilimumab, nivolumab or pembrolizumab)

Brain Metastases · Brain Metastases

#BrainMetastases#Antibody#Preclinical#monoclonal-antibody#Bristol
Trials 1Status Active
AntibodyLimited DatastaleInSightecPhase 3

Iptilimumab (Iptilimumab)

Brain Tumor; Non Small Cell Lung Cancer · Brain Tumor

#BrainTumor#Antibody#Phase3#monoclonal-antibody#NonSmallCellLungCancer+1
Trials 1Status Recruiting
AntibodyLimited DatastaleM.D. Anderson Cancer CenterPhase 2

Standard Dose Bevacizumab (Standard Dose Bevacizumab)

Brain Cancer; Glioblastoma · Brain Cancer

#BrainCancer#Antibody#Phase2#monoclonal-antibody#Glioblastoma+1
Trials 1Status Active
AntibodyLimited DatastaleBeiGenePhase 2

Tislelizumab plus Bevacizumab (Tislelizumab plus Bevacizumab)

Astrocytoma of Brain · Astrocytoma of Brain

#AstrocytomaofBrain#Antibody#Phase2#monoclonal-antibody#BeiGene
Trials 1Status Recruiting
AntibodyLimited DatastaleBeijing Biostar Pharmaceuticals…Phase 2

Utidelone combined with Bevacizumab (Utidelone combined with Bevacizumab)

Non-small Cell Lung Cancer Patients with Brain Metastases · Non-small Cell Lung Cancer Patients with

#Non-smallCellLungCancerPatientsw#Antibody#Phase2#monoclonal-antibody#Beijing
Trials 1Status Recruiting
AntibodyLimited DatastaleKaty PetersPhase 2

Vorinostst/Bevacizumab/Temozolomide (Vorinostst/Bevacizumab/Temozolomide)

Brain Tumor; Glioblastoma · Brain Tumor

#BrainTumor#Antibody#Phase2#monoclonal-antibody#Glioblastoma+1
Trials 1Status Active